Cardinal Health Inc
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Cardinal Health Inc (CAH). It shows which part of the business is growing — and which one is holding it back.
Revenue by business segment
| Segment | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|---|
| Pharmaceutical and Specialty Solutions | $47.99B 91.8% | $50.85B 92.0% | $50.43B 91.9% | $59.21B 92.5% | $60.67B 92.4% · +26.4% | $56.11B 92.0% · +10.3% |
| GMPD | $3.12B 6.0% | $3.15B 5.7% | $3.16B 5.8% | $3.18B 5.0% | $3.26B 5.0% · +4.4% | $3.15B 5.2% · -0.2% |
| Other Operating Segment | $1.19B 2.3% | $1.28B 2.3% | $1.30B 2.4% | $1.64B 2.6% | $1.72B 2.6% · +45.4% | $1.71B 2.8% · +33.0% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
| Segment | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|---|
| Pharmaceutical and Specialty Solutions | $530.0M 1.1% | $531.0M 1.0% | $662.0M 1.3% | $667.0M 1.1% | $687.0M 1.1% | $784.0M 1.4% |
| GMPD | $8.0M 0.3% | $18.0M 0.6% | $39.0M 1.2% | $46.0M 1.4% | $37.0M 1.1% | $25.0M 0.8% |
| Other Operating Segment | $104.0M 8.8% | $118.0M 9.2% | $134.0M 10.3% | $166.0M 10.1% | $179.0M 10.4% | $179.0M 10.5% |
Large figure: segment operating income. Below it the margin, that is operating income measured against the revenue of the same segment.
Revenue by region
| Segment | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|---|
| UNITED STATES | $51.89B 99.2% | $54.86B 99.2% | $54.50B 99.3% | $63.61B 99.3% | $65.22B 99.3% · +25.7% | $60.54B 99.3% · +10.4% |
| Non-US | $408.0M 0.8% | $428.0M 0.8% | $399.0M 0.7% | $419.0M 0.7% | $435.0M 0.7% · +6.6% | $423.0M 0.7% · -1.2% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Operating metrics
Operating metrics are the figures a company uses to measure its own business — customer counts, stores, deliveries or the churn rate. None of them appear in the financial statements, and they often explain earlier than revenue does why revenue is moving.
| Metric | Q1 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|
| Solaris Health providers | – | 750 | 750 | 750 |
| Solaris Health practice locations | – | 250 | 250 | 250 |
| Solaris Health states | – | 14 | 14 | 14 |
These metrics are not part of the financial statements; they sit in the narrative text of the filings. We read them out of the SEC filings using artificial intelligence and check every single figure against the original passage in the report; anything that is not found there verbatim is discarded. Source: SEC EDGAR (annual and quarterly reports, 10-K/10-Q).
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.